AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The most common side …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …
List of 21 Tardive Dyskinesia Medications Compared - Drugs.com
Mar 5, 2024 · Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine (Ingrezza), tetrabenazine (Xenazine), amantadine, vitamin B6 (pyridoxine) and pyridoxal …
What are the treatment options for tardive dyskinesia?
Oct 25, 2025 · Treatment Options for Tardive Dyskinesia The most effective treatments for tardive dyskinesia are the FDA-approved VMAT2 inhibitors valbenazine and deutetrabenazine, which should …
Austedo (Deutetrabenazine): Uses & Side Effects
Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.
What Is Tardive Dyskinesia? Causes, Symptoms & Treatment
3 days ago · Tardive dyskinesia is a movement disorder caused most often by long-term use of certain medicines that block dopamine. If you have tardive dyskinesia , you will notice repeated, involuntary …
Austedo XR Approved: A New Treatment Option for Tardive ...
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
Nov 7, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.
Austedo XR: FDA Approved for tardive Dyskinesia
Jun 1, 2024 · In a significant advancement for those suffering from tardive dyskinesia (TD), the U.S. Food and Drug Administration (FDA) recently approved Austedo XR (extended-release …
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine ...
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …